APA (7th ed.) Citation

AR, B., G, V., M, C., G, D. L., V, T., P, C., . . . R, L. (2022). Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: A multicentric Italian retrospective study. Journal of neurology, 269(6), 3301. https://doi.org/10.1007/s00415-022-11009-x

Chicago Style (17th ed.) Citation

AR, Buonomo, et al. "Management of Hepatitis B Virus Prophylaxis in Patients Treated with Disease-modifying Therapies for Multiple Sclerosis: A Multicentric Italian Retrospective Study." Journal of Neurology 269, no. 6 (2022): 3301. https://doi.org/10.1007/s00415-022-11009-x.

MLA (9th ed.) Citation

AR, Buonomo, et al. "Management of Hepatitis B Virus Prophylaxis in Patients Treated with Disease-modifying Therapies for Multiple Sclerosis: A Multicentric Italian Retrospective Study." Journal of Neurology, vol. 269, no. 6, 2022, p. 3301, https://doi.org/10.1007/s00415-022-11009-x.